THE WHAT? The Court docket of Justice of the European Union (CJEU) has dismissed appeals from the French authorities and European Fee, confirming the annulment of the EU classification of titanium dioxide powder as a suspected inhalation carcinogen, citing flawed scientific evaluation.
THE DETAILS The dispute centred on the EU’s 2020 classification of titanium dioxide in powder type (with ≥1% of particles ≤10μm in diameter) as a Class 2 carcinogen by inhalation underneath the CLP Regulation. Business teams challenged the classification, arguing that the European Chemical substances Company’s Threat Evaluation Committee (RAC) relied too closely on a single animal inhalation research (Heinrich et al., 1995) and utilized incorrect parameters for “lung overload” calculations. The Normal Court docket annulled the classification in 2022, discovering manifest errors within the evaluation and inadequate consideration of particle agglomeration results. On attraction, the CJEU dominated that the Normal Court docket had not overstepped its judicial assessment powers and upheld findings that the RAC did not take all related scientific elements under consideration. The ruling leaves the titanium dioxide classification void except reassessed by means of a brand new regulatory course of.
THE WHY? The judgment underscores the EU courts’ willingness to scrutinise the scientific foundations of chemical hazard classifications, signalling that regulators should exhibit rigorous, clear, and full consideration of accessible proof—notably when such classifications have important industrial and compliance impacts for sectors akin to coatings, plastics, and cosmetics.
Supply: Curia Europa
